课题基金 / 基金详情

Project 3 - Ex vivo immune profiling of dengue viruses and vaccines

Project 3 - Ex vivo immune profiling of dengue viruses and vaccines
项目 3 - 登革热病毒和疫苗的离体免疫分析
批准号：
10330073
负责人：
Ana Fernandez-Sesma
金额：
$15.27万
依托单位：
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
项目状态：
已结题
起止时间：
2021-02-11 至 2022-05-31
来源：
https://reporter.nih.gov/project-details/10330073
关键词：
2019-nCoVAddressAdministrative SupplementAdultCOVID-19 pandemicChildDengue VaccineEnrollmentEpidemiologyFundingHealthHouseholdHumanImmuneLung diseasesMonitorNational Institute of Allergy and Infectious DiseaseParticipantPediatric ResearchPopulationSerologySurveysTestingUnited States National Institutes of Healthdesignepidemiologic datainfection burdeninfection ratememberprospectiveresearch studyresponse

项目摘要

项目成果

Ana Fernandez-Sesma的其他基金

相似基金

相关文献

中文摘要
翻译
2019冠状病毒病大流行是美国人口面临的最重要的健康挑战， 世纪。大多数流行病学数据都集中在导致严重呼吸道感染的病例上。 主要见于成人的疾病。关于感染负担的信息不足， 特别是在受到前瞻性监测的家庭中， 通过重复测试。这一信息对于确定沉默和症状是至关重要的 儿童感染率。NIAID支持的人类流行病学和对SARS的反应- CoV-2（HEROS）调查研究旨在填补这一空白。
英文摘要
The COVID-19 pandemic is the most important health challenge to the US population within a century. Most epidemiological data have focused on cases that resulted in severe respiratory disease seen predominantly in adults. Inadequate information regarding the infection burden in children is available, especially in the context of households that are prospectively monitored with repetitive testing. This information is critical to determine the silent and symptomatic infection rate in children. The NIAID-supported Human Epidemiology and Response to SARS- CoV-2 (HEROS) survey study is designed to fill this gap.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immune Phenotyping Core
Immune phenotyping of human immune responses to dengue vaccination and challenge
Viral Immunity and VAccination (VIVA) Human Immunology Project Consortium (HIPC)
Administrative Core
海外基金